Page 12 - Beckley Psytech News Today

17 Dec 2020 Share: More and more revolutionary mind-altering medicines and treatments based on active ingredients previously spurned as street drugs, such as ketamine and psilocybin (magic mushrooms), are gaining acceptance with regulators. Clinical trials show psychedelics have huge potential to help people with treatment resistant mental illnesses including depression, addiction, anxiety and inflammation. So, with the launch of its first investment fund, will the psychedelic healthcare ...

Noetic Psychedelic Fund LP Closing to New Accredited Investors December 31st, 2020 and Announcing the Launch of Noetic Fund II in February 2021 Noetic Funds," founded by the team at Grey House Partners GP Inc., is a pre-eminent venture fund led by experienced venture capitalists, hedge fund managers and operators to help nurture and grow companies poised to disrupt the traditional global pharmaceutical supply chain. Psychedelic medicine has the potential to cure global ailments, including the...